FDA Inspection 1117803 — AcelRx Pharmaceuticals, Inc.
The FDA completed an inspection of AcelRx Pharmaceuticals, Inc. on Feb 13, 2020 in Hayward, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 13, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hayward, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)